Abbott Laboratories
Open
$90.38
Prev. Close
$90.35
High
$90.69
Low
$90.38
Market Snapshot
$157.47B
25.1
7.66
$41.95B
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 115,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
Representative Julie Johnson sold shares of Abbott Laboratories valued between $2,002 and $30,000, highlighting ongoing scrutiny of financial transactions by public officials in healthcare.
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 115,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
Recently from Cashu
Abbott Laboratories Launches Libre Duo to Combat Rising Diabetic Ketoacidosis Rates in Europe
Abbott Laboratories (Ticker: ABT) takes a significant step in enhancing diabetes management with the introduction of its Libre Duo and Libre Duo 10 Day continuous monitoring systems for glucose and ke…
Abbott Laboratories Unveils Innovative Cardiac Technologies at Heart Rhythm Society 2026 Conference
Abbott Laboratories (NYSE: ABT) has made a significant impression at the Heart Rhythm Society 2026 conference held in Chicago, presenting groundbreaking findings from multiple clinical trials that und…
Abbott Laboratories to Acquire Exact Sciences for $21 Billion to Enhance Diagnostics Focus
Abbott Laboratories announces its intention to acquire Exact Sciences for $21 billion in a major move within the healthcare sector. This acquisition is significant as it represents the largest healthc…
Abbott Laboratories Progresses Toward FDA Submission with Innovative Medical Device Studies
Abbott Laboratories Sets Sights on FDA Submission with Innovative Device Studies Abbott Laboratories is making significant strides in the regulatory pathway for its latest innovative medical device, a…